-
公开(公告)号:WO2023283586A2
公开(公告)日:2023-01-12
申请号:PCT/US2022/073476
申请日:2022-07-06
Inventor: TRIPP, Ralph A. , MURRAY, Jackelyn , KARUMANCHI, Devi Kalyan , MARTIN, David Eugene
IPC: C07C15/02 , A61K31/145 , C07C311/15 , A23K20/111 , A23K50/30 , A23K50/75 , A23L29/03 , A23L29/035 , A23L29/045 , A23L29/055 , A61P13/00 , A61P19/06 , A61P31/12 , C07C311/16 , C07D295/26
Abstract: Probenecid prodrug compounds, and formulations including one or more of probenecid, metabolites and analogs thereof, and prodrugs thereof, and pharmaceutically acceptable salt thereof are provided. Delivery vehicles and pharmaceutical compositions including any of the foregoing are also provided. Methods of using the compounds and compositions to treat viral infections are also provided. In some embodiments, the viral infection is caused by an RNA virus. Particular viruses include, but are not limited to, influenza virus A, influenza virus B, or influenza virus C, respiratory syncytial virus (RSV), coronaviruses, measles virus, mumps virus, Zika virus, and dengue virus. Dosage regimens are also provided.
-
公开(公告)号:WO2020050215A1
公开(公告)日:2020-03-12
申请号:PCT/JP2019/034432
申请日:2019-09-02
Applicant: 国立大学法人東京工業大学
IPC: C07B33/00 , B01J23/34 , C01G45/02 , C07B41/06 , C07B41/08 , C07B45/04 , C07C45/38 , C07C45/39 , C07C47/54 , C07C49/78 , C07C49/786 , C07C303/36 , C07C311/16 , C07C311/29 , C07D307/46 , C07B61/00
Abstract: 効率的な酸化物の製造を目的として、原料化合物を酸素の存在下で酸化し、酸化物を製造する方法であって、結晶構造がβ型である二酸化マンガンの存在下で、原料化合物を酸化することを特徴とする酸化物の製造方法を提供する。
-
公开(公告)号:WO2019040380A1
公开(公告)日:2019-02-28
申请号:PCT/US2018/047112
申请日:2018-08-20
Applicant: VIVACE THERAPEUTICS, INC.
Inventor: KONRADI, Andrei W. , LIN, Tracy Tzu-Ling Tang
IPC: A61K31/18 , A61K31/135 , A61K31/635 , C07C311/16
Abstract: Provided herein are compounds and pharmaceutical compositions comprising said compounds that are useful for treating cancers. Specific cancers include those that are mediated by YAP/TAZ or those that are modulated by the interaction between YAP/TAZ and TEAD.
-
公开(公告)号:WO2018181986A1
公开(公告)日:2018-10-04
申请号:PCT/JP2018/013853
申请日:2018-03-30
Applicant: 国立大学法人東北大学
IPC: C07C211/29 , A61K31/137 , A61K31/165 , A61K31/17 , A61K31/18 , A61K31/27 , A61K31/4402 , A61K31/4406 , A61P3/10 , A61P25/16 , A61P25/18 , A61P25/28 , A61P43/00 , C07C215/38 , C07C233/05 , C07C233/13 , C07C233/18 , C07C235/06 , C07C237/06 , C07C271/14 , C07C275/28 , C07C311/09 , C07C311/16 , C07C323/41 , C07D213/40 , C07D213/81
CPC classification number: A61K31/137 , A61K31/165 , A61K31/17 , A61K31/18 , A61K31/27 , A61K31/4402 , A61K31/4406 , A61P3/10 , A61P25/16 , A61P25/18 , A61P25/28 , A61P43/00 , C07C211/29 , C07C215/38 , C07C233/05 , C07C233/13 , C07C233/18 , C07C235/06 , C07C237/06 , C07C271/14 , C07C275/28 , C07C311/09 , C07C311/16 , C07C323/41 , C07D213/40 , C07D213/81
Abstract: 本発明により、式(I)で表される化合物、そのエナンチオマー、そのジアステレオマー、または医薬として許容なその塩を含む、認知機能疾患または障害の治療または予防のための医薬組成物が提供される。
-
公开(公告)号:WO2018179343A1
公开(公告)日:2018-10-04
申请号:PCT/JP2017/013616
申请日:2017-03-31
Applicant: 国立大学法人東北大学
IPC: C07C211/27 , A61K31/13 , A61K31/16 , A61K31/175 , A61K31/18 , A61K31/27 , A61P3/10 , A61P25/16 , A61P25/28 , A61P43/00 , C07C211/63 , C07C247/06 , C07C271/14 , C07C275/28 , C07C311/03 , C07C311/16
CPC classification number: A61K31/13 , A61K31/16 , A61K31/175 , A61K31/18 , A61K31/27 , A61P3/10 , A61P25/16 , A61P25/28 , A61P43/00 , C07C211/27 , C07C211/63 , C07C247/06 , C07C271/14 , C07C275/28 , C07C311/03 , C07C311/16
Abstract: 本発明により、式(I)で表される化合物、そのエナンチオマー、そのジアステレオマー、または医薬として許容なその塩を含む、認知機能疾患または障害の治療または予防のための医薬組成物が提供される。
-
6.
公开(公告)号:WO2018104307A1
公开(公告)日:2018-06-14
申请号:PCT/EP2017/081533
申请日:2017-12-05
Applicant: BAYER PHARMA AKTIENGESELLSCHAFT
Inventor: WERNER, Stefan , MESCH, Stefanie , BRAEUER, Nico
IPC: C07D231/12 , A61K31/18 , A61K31/40 , A61K31/415 , A61K31/4155 , A61K31/42 , A61K31/44 , A61K31/445 , C07C311/16 , C07C311/17 , C07D401/12 , C07D261/08 , C07D207/10 , C07D213/34 , C07D213/61 , A61P29/00
CPC classification number: C07D213/34 , A61K45/06 , A61P29/00 , C07C311/17 , C07C311/40 , C07C311/46 , C07C311/51 , C07C2601/02 , C07D207/10 , C07D213/61 , C07D231/12 , C07D261/08 , C07D401/12 , C07D405/04
Abstract: Substituted aromatic sulfonamides of formula (I), pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease.
-
7.
公开(公告)号:WO2018093694A1
公开(公告)日:2018-05-24
申请号:PCT/US2017/061221
申请日:2017-11-13
Applicant: MERCK SHARP & DOHME CORP. , GRESHOCK, Thomas, J. , MULHEARN, James, J. , ROECKER, Anthony, J. , JIAN, Tianying , ZHOU, Gang , GUO, Liangqin , WON, Walter , ZHANG, Ting , ANAND, Rajan , STELMACH, John, E. , WANG, Deping , KIM, Ronald, M. , LAYTON, Mark, E. , BURGEY, Christopher, S. , NANTERMET, Philippe, G.
Inventor: GRESHOCK, Thomas, J. , MULHEARN, James, J. , ROECKER, Anthony, J. , JIAN, Tianying , ZHOU, Gang , GUO, Liangqin , WON, Walter , ZHANG, Ting , ANAND, Rajan , STELMACH, John, E. , WANG, Deping , KIM, Ronald, M. , LAYTON, Mark, E. , BURGEY, Christopher, S. , NANTERMET, Philippe, G.
IPC: A61K31/18 , A61K31/38 , A61K31/395 , C07C311/15 , C07C311/16 , C07D285/00
Abstract: Disclosed are compounds of Formula A, or a salt thereof: Formula (A), wherein: Het, Q and R 1A to R 4A are defined herein, which compounds have properties for blocking Na v 1.7 ion channels found in peripheral and sympathetic neurons. Also described are pharmaceutical formulations comprising the compounds of Formula A or their salts, and methods of treating cough, itch, acute pain and neuropathic pain disorders using the same.
-
公开(公告)号:WO2017135786A1
公开(公告)日:2017-08-10
申请号:PCT/KR2017/001288
申请日:2017-02-06
Applicant: 연세대학교 산학협력단 , 한국화학연구원
IPC: C07D409/04 , C07D409/14 , C07D277/22 , C07C311/16 , A61K31/4155 , A61K31/426 , A61K31/18
CPC classification number: A61K31/18 , A61K31/4155 , A61K31/426 , C07C311/16 , C07D277/22 , C07D409/04 , C07D409/14
Abstract: 본 발명은 골질환의 예방 또는 치료에 유용하게 사용될 수 있는 신규한 아미드 화합물 및 이의 용도에 관한 것이다.
Abstract translation: 本发明涉及用于预防或治疗骨疾病及其用途的新型酰胺化合物。 p>
-
公开(公告)号:WO2017106820A1
公开(公告)日:2017-06-22
申请号:PCT/US2016/067470
申请日:2016-12-19
Inventor: BEN-TAL, Nir , ARMEN, Roger S. , EISENLOHR, Laurence C. , BELANI, Jitendra , MILLER, Michael , FISH, Inbar , KALID, Ori
IPC: A61P31/16 , C07C311/16 , C07C311/29
CPC classification number: C07C311/16
Abstract: An effective therapeutic agent for the M2 channel comprising sulfonylamide or oxabicyclo structures effective for treating amantadine-resistant influenza A infections, and methods of treating amantadine-resistant influenza A infections through adminstration of the same.
Abstract translation: 包含磺酰胺或氧杂双环结构的M2通道的有效治疗剂,所述治疗剂可有效治疗耐受金刚烷胺的A型流感感染,以及通过施用治疗金刚烷胺耐药的A型流感感染的方法。 p >
-
公开(公告)号:WO2017104589A1
公开(公告)日:2017-06-22
申请号:PCT/JP2016/086837
申请日:2016-12-12
Applicant: 国立研究開発法人理化学研究所
IPC: C07B37/04 , C07B37/08 , C07B47/00 , C07C17/263 , C07C21/18 , C07C22/00 , C07C22/08 , C07C29/32 , C07C31/38 , C07C41/30 , C07C43/205 , C07C45/68 , C07C49/167 , C07C67/293 , C07C69/78 , C07C303/40 , C07C311/16 , C07D203/24 , C07D207/444 , C07D209/34 , C07D279/02 , C07B61/00
CPC classification number: C07B37/04 , C07B37/08 , C07B47/00 , C07B61/00 , C07C17/263 , C07C21/18 , C07C22/00 , C07C22/08 , C07C29/32 , C07C31/38 , C07C41/30 , C07C43/205 , C07C45/68 , C07C49/167 , C07C67/293 , C07C69/78 , C07C303/40 , C07C311/16 , C07D203/24 , C07D207/444 , C07D209/34 , C07D279/02
Abstract: 安価かつ安全に、パーフルオロアルキル化化合物を効率よく製造する方法を提供する。 ビス(パーフルオロアルカノイル)パーオキシドと、炭素-炭素不飽和結合、及び/又は芳香環に結合した水素原子を有する芳香環を含む化合物とを銅触媒の存在下で反応させることを含むパーフルオロアルキル化化合物の製造方法。
Abstract translation: 提供了一种廉价而安全地有效生产全氟烷基化合物的方法。 和双(全氟链烷酰基)过氧化物,碳 - 碳不饱和键,和/或含有具有芳环的化合物的全氟烷基在存在具有氢原子的铜催化剂的键合在芳香环反应 生产化合物的方法。 p>
-
-
-
-
-
-
-
-
-